Medtronic received information via literature regarding freestyle aortic root prosthesis in combination with aortic replacement and open anastomosis.All data were collected retrospectively from a single center between september 2007 and march 2017.The study population included 278 patients (predominantly male, mean age 62 years), all of which were implanted with medtronic freestyle aortic root bioprosthesis (unique device identifier numbers not provided).The patients were divided into two groups for comparison: 119 in the open arch anastomosis (oa) group and 152 in the non-open arch anastomosis (non-oa) group.Among all patients, 16 total deaths occurred (8 from the oa and 8 from the non-oa groups).In the oa group, 4 of 8 in-hospital deaths occurred due to acute type a dissection.In longer term follow-up, one patient died four years after implant due to heart failure with noted moderate valvular regurgitation.Based on the available information medtronic product may have been associated with the death(s).Among all patients, adverse events included: stroke, bleeding requiring intervention, tamponade, myocardial infarction (mi), endocarditis requiring intervention, structural valve dysfunction (svd) causing ¿moderate to severe impairment¿, and dissection requiring intervention.Based on the available information medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
|